- Home
- BMR vs IXHL Comparison
BMR vs IXHL Comparison
Compare BMR & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BMR | IXHL |
|---|---|---|
| Founded | 2009 | 2001 |
| Country | Israel | Australia |
| Employees | N/A | 12 |
| Industry | Computer Software: Prepackaged Software | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.4M | 134.7M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | BMR | IXHL |
|---|---|---|
| Price | $1.94 | $0.39 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 122.4K | ★ 10.9M |
| Earning Date | 08-13-2025 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,131,000.00 | $12,000.00 |
| Revenue This Year | $21.21 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 5.96 | N/A |
| 52 Week Low | $1.54 | $0.08 |
| 52 Week High | $4.87 | $2.25 |
Technical Indicators
Market Signals| Indicator | BMR | IXHL |
|---|---|---|
| Relative Strength Index (RSI) | 47.64 | 50.08 |
| Support Level | $1.54 | $0.35 |
| Resistance Level | $2.03 | $0.42 |
| Average True Range (ATR) | 0.13 | 0.03 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 75.00 | 40.03 |
Price Performance
Historical ComparisonAbout BMR Beamr Imaging Ltd.
Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.